Should myeloma patients stay on maintenance therapy for several years?


In this week’s video, Dr. Brian G.M. Durie explains that maintenance therapy can prolong remissions and delay relapse.

The BOTTOM LINE: If maintenance therapy is well-tolerated, stick with it!

Have a question? Submit it to

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at